Chemotherapy for small-cell lung cancer

H. Ueoka; K. Kiura; M. Tabata; A. Bessho; A. Matsushita; K. Chikamori; H. Yamane; M. Harada; I. Kimura; T. Ohnoshi

Chemotherapy for small-cell lung cancer

H. Ueoka, K. Kiura, M. Tabata, A. Bessho, A. Matsushita, K. Chikamori, H. Yamane, M. Harada, I. Kimura, T. Ohnoshi

University Hospital

Research output: Contribution to journal › Article › peer-review

Abstract

Here we review the current treatments for small-cell lung cancer. Cisplatin and etoposide, combined with concurrent or alternating thoracic irradiation, have been considered to be the standard therapy for patients with limited disease. Dose-intensive weekly chemotherapy and high-dose chemotherapy with autologous stem cell transplantation have failed to increase survival in patients with extensive disease. Promising new drugs such as irinotecan and taxol may improve survival in patients with extensive disease.

Original language	English
Pages (from-to)	87-91
Number of pages	5
Journal	Japanese Journal of Thoracic Diseases
Volume	34
Issue number	SUPPL.
Publication status	Published - 1996

Keywords

Chemotherapy
Dose-intensive chemotherapy
High-dose chemotherapy
Small-cell lung cancer
Thoracic irradiation

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{aeebb5416b5f4cab9329e93139d028a4,

title = "Chemotherapy for small-cell lung cancer",

abstract = "Here we review the current treatments for small-cell lung cancer. Cisplatin and etoposide, combined with concurrent or alternating thoracic irradiation, have been considered to be the standard therapy for patients with limited disease. Dose-intensive weekly chemotherapy and high-dose chemotherapy with autologous stem cell transplantation have failed to increase survival in patients with extensive disease. Promising new drugs such as irinotecan and taxol may improve survival in patients with extensive disease.",

keywords = "Chemotherapy, Dose-intensive chemotherapy, High-dose chemotherapy, Small-cell lung cancer, Thoracic irradiation",

author = "H. Ueoka and K. Kiura and M. Tabata and A. Bessho and A. Matsushita and K. Chikamori and H. Yamane and M. Harada and I. Kimura and T. Ohnoshi",

year = "1996",

language = "English",

volume = "34",

pages = "87--91",

journal = "Respiratory Investigation",

issn = "2212-5345",

publisher = "Elsevier BV",

number = "SUPPL.",

}

TY - JOUR

T1 - Chemotherapy for small-cell lung cancer

AU - Ueoka, H.

AU - Kiura, K.

AU - Tabata, M.

AU - Bessho, A.

AU - Matsushita, A.

AU - Chikamori, K.

AU - Yamane, H.

AU - Harada, M.

AU - Kimura, I.

AU - Ohnoshi, T.

PY - 1996

Y1 - 1996

N2 - Here we review the current treatments for small-cell lung cancer. Cisplatin and etoposide, combined with concurrent or alternating thoracic irradiation, have been considered to be the standard therapy for patients with limited disease. Dose-intensive weekly chemotherapy and high-dose chemotherapy with autologous stem cell transplantation have failed to increase survival in patients with extensive disease. Promising new drugs such as irinotecan and taxol may improve survival in patients with extensive disease.

AB - Here we review the current treatments for small-cell lung cancer. Cisplatin and etoposide, combined with concurrent or alternating thoracic irradiation, have been considered to be the standard therapy for patients with limited disease. Dose-intensive weekly chemotherapy and high-dose chemotherapy with autologous stem cell transplantation have failed to increase survival in patients with extensive disease. Promising new drugs such as irinotecan and taxol may improve survival in patients with extensive disease.

KW - Chemotherapy

KW - Dose-intensive chemotherapy

KW - High-dose chemotherapy

KW - Small-cell lung cancer

KW - Thoracic irradiation

UR - http://www.scopus.com/inward/record.url?scp=0030438360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030438360&partnerID=8YFLogxK

M3 - Article

C2 - 9216192

AN - SCOPUS:0030438360

SN - 2212-5345

VL - 34

SP - 87

EP - 91

JO - Respiratory Investigation

JF - Respiratory Investigation

IS - SUPPL.

ER -

Chemotherapy for small-cell lung cancer

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this